Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study.
Publicado: Lun Nov 30, 2015 7:30 pm
Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study.
Myeloma UK
Eur J Cancer Care (Engl). 2015 Nov 25.
"A new treatment paradigm has emerged with many patients now receiving oral chemotherapy (OC) as first-line treatment for cancer. Treatment with OC has resulted in reduced hospital costs, more autonomy for patients but with added responsibilities for patient self-management...."
Mas en:
http://www.ncbi.nlm.nih.gov/pubmed/26603371
leer tambien:
Ann Oncol. 2015 Nov 16. pii: mdv563. [Epub ahead of print]
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared to hospital administration: results of a prospective single-center study.
http://www.ncbi.nlm.nih.gov/pubmed/26578729
Myeloma UK
Eur J Cancer Care (Engl). 2015 Nov 25.
"A new treatment paradigm has emerged with many patients now receiving oral chemotherapy (OC) as first-line treatment for cancer. Treatment with OC has resulted in reduced hospital costs, more autonomy for patients but with added responsibilities for patient self-management...."
Mas en:
http://www.ncbi.nlm.nih.gov/pubmed/26603371
leer tambien:
Ann Oncol. 2015 Nov 16. pii: mdv563. [Epub ahead of print]
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared to hospital administration: results of a prospective single-center study.
http://www.ncbi.nlm.nih.gov/pubmed/26578729